Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
| 128 | 3 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//HEALTH LITERACY//INFORMED CONSENT | 68930 |
| 981 | 2 | EVIDENCE BASED MEDICINE//RESEARCH SYNTHESIS METHODS//PUBLICATION BIAS | 10885 |
| 30169 | 1 | BENEFIT RISK//BENEFIT RISK ASSESSMENT//BENEFIT RISK COMMUNICATION | 189 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | BENEFIT RISK | authKW | 1708537 | 13% | 41% | 25 |
| 2 | BENEFIT RISK ASSESSMENT | authKW | 527006 | 8% | 20% | 16 |
| 3 | BENEFIT RISK COMMUNICATION | authKW | 333512 | 1% | 100% | 2 |
| 4 | BENEFIT RISK FRAMEWORK | authKW | 333512 | 1% | 100% | 2 |
| 5 | BENEFIT RISK METHODOLOGIES | authKW | 333512 | 1% | 100% | 2 |
| 6 | CUSTOM MADE MEDICINE | authKW | 333512 | 1% | 100% | 2 |
| 7 | GLOBAL REGULATORY AFFAIRS NEUROSCI | address | 333512 | 1% | 100% | 2 |
| 8 | PHARMACOVIGILANCE MED SAFETY | address | 333512 | 1% | 100% | 2 |
| 9 | REGULATORY AFFAIRS EUROPE | address | 333512 | 1% | 100% | 2 |
| 10 | BENEFIT HARM ASSESSMENT | authKW | 222340 | 1% | 67% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Medical Informatics | 2656 | 15% | 0% | 28 |
| 2 | Health Care Sciences & Services | 1687 | 21% | 0% | 39 |
| 3 | Statistics & Probability | 1612 | 23% | 0% | 43 |
| 4 | Pharmacology & Pharmacy | 1446 | 51% | 0% | 96 |
| 5 | Mathematical & Computational Biology | 865 | 13% | 0% | 24 |
| 6 | Public, Environmental & Occupational Health | 325 | 18% | 0% | 34 |
| 7 | Health Policy & Services | 140 | 5% | 0% | 9 |
| 8 | Toxicology | 55 | 6% | 0% | 11 |
| 9 | Medicine, Research & Experimental | 44 | 7% | 0% | 13 |
| 10 | Economics | 17 | 4% | 0% | 8 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | GLOBAL REGULATORY AFFAIRS NEUROSCI | 333512 | 1% | 100% | 2 |
| 2 | PHARMACOVIGILANCE MED SAFETY | 333512 | 1% | 100% | 2 |
| 3 | REGULATORY AFFAIRS EUROPE | 333512 | 1% | 100% | 2 |
| 4 | CLIN DEV BIOSTAT 1 | 222340 | 1% | 67% | 2 |
| 5 | REGULATORY EXCELLENCE | 222340 | 1% | 67% | 2 |
| 6 | AUTON PHARMACOVIGILANCE | 166756 | 1% | 100% | 1 |
| 7 | BENEFIT RISK ASSESSMENT | 166756 | 1% | 100% | 1 |
| 8 | CLIN REPORTING SYST | 166756 | 1% | 100% | 1 |
| 9 | COM RD | 166756 | 1% | 100% | 1 |
| 10 | DIPARTIMENTO SCI MATEMAT DISMA GIUSEPPE LUIGI LAG | 166756 | 1% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | THERAPEUTIC INNOVATION & REGULATORY SCIENCE | 105899 | 8% | 4% | 16 |
| 2 | DRUG INFORMATION JOURNAL | 49082 | 10% | 2% | 18 |
| 3 | STATISTICS IN BIOPHARMACEUTICAL RESEARCH | 40790 | 5% | 3% | 9 |
| 4 | PHARMACEUTICAL STATISTICS | 24858 | 5% | 2% | 9 |
| 5 | JOURNAL OF BIOPHARMACEUTICAL STATISTICS | 17207 | 5% | 1% | 10 |
| 6 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 8382 | 6% | 0% | 11 |
| 7 | CLINICAL TRIALS | 7626 | 3% | 1% | 6 |
| 8 | VALUE IN HEALTH | 3521 | 3% | 0% | 6 |
| 9 | DRUG SAFETY | 1940 | 3% | 0% | 5 |
| 10 | JOURNAL OF CLINICAL EPIDEMIOLOGY | 1706 | 4% | 0% | 7 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |